UPDATE 3-U.S. FDA panel backs Amgen copy of AbbVie arthritis drug Humira
 

UPDATE 3-U.S. FDA panel backs Amgen copy of AbbVie arthritis drug Humira
July 12 (Reuters) - Amgen Inc's cheaper version ofAbbVie's top-selling arthritis drug Humira is highlysimilar to the original and should be approved, an advisorypanel to the U.S. Food and Drug...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...ps:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...ps:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/n56yLXHD1iI